Telcare Names Rick O'Connor as Senior Vice President of Marketing

BETHESDA, MD--(Marketwired - Apr 8, 2015) - Telcare, the provider of the world's first cellular-enabled blood glucometer, diabetes mobile application, and comprehensive HIPAA compliant cloud platform, today bolstered its executive team with the addition of former CVS Health marketer Rick O'Connor as senior vice president of marketing.

The addition of Rick O'Connor is on the heels of Telcare's $32.5 million funding round in October, along with a recent technology patent allowance supporting improved diabetes care, solidifying Telcare as the leader in cellular-enabled blood glucometers and digital health. In this new role Rick will drive Telcare's marketing and communications initiatives, including a refreshed go-to-market strategy. He will be responsible for all B2B activity and developing Telcare's patient engagement and retention efforts.

"Telcare is at the heart of the revolution transforming digital health today," said Andy Flanagan, Telcare CEO. "As consumers and health providers try to decipher the various mobile medical apps and devices, Rick's strategic thinking, wealth of industry experience and leadership skills will help Telcare continue to set itself apart from the competition and deliver world-class disease management solutions."

Rick brings over 25 years of health care and marketing experience, including serving at Chief Marketing Officer for the Caremark division of CVS Health, where he drove product marketing, member engagement, strategic sales communications support. He played an integral role in the development of the new corporate name (CVS Health) and was the marketing co-led on the campaign developed around the new name and the simultaneous removal of tobacco from all CVS retail stores. He also served as vice president of product marketing for Aetna Inc., and also led the creation of the individual insurance portal, growing that business from one state to thirty states. 

"The digital health industry is still in its infancy and it will be what drives the required connection of patients, the payers and the providers to achieve radically improved results. Telcare's unique approach, and its FDA-cleared device set it above the competition," said Rick O'Connor. "The leadership team Andy is building is setting the stage to vastly improve the lives of those living with diabetes."

About Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular blood glucometer. Headquartered in Bethesda, Maryland, Telcare is a privately-held company funded by Norwest Venture Partners, The Qualcomm Life Fund, Sequoia Capital, Mosaic Health Solutions and other founding investors. For more information, visit www.telcare.com.